PIERINI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.707
AS - Asia 2.044
EU - Europa 1.807
SA - Sud America 407
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 57
OC - Oceania 4
Totale 7.251
Nazione #
US - Stati Uniti d'America 2.622
SG - Singapore 973
IT - Italia 528
CN - Cina 348
BR - Brasile 308
IE - Irlanda 294
RU - Federazione Russa 247
HK - Hong Kong 233
VN - Vietnam 158
FR - Francia 136
DE - Germania 132
FI - Finlandia 110
KR - Corea 74
GB - Regno Unito 65
SE - Svezia 57
IN - India 53
UA - Ucraina 50
BD - Bangladesh 48
AT - Austria 46
CA - Canada 38
TR - Turchia 31
AR - Argentina 30
MX - Messico 26
PL - Polonia 26
NL - Olanda 23
EC - Ecuador 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
PK - Pakistan 17
ZA - Sudafrica 16
BE - Belgio 14
CH - Svizzera 14
SA - Arabia Saudita 14
CO - Colombia 13
ID - Indonesia 11
JP - Giappone 11
VE - Venezuela 10
PH - Filippine 9
MA - Marocco 8
RO - Romania 8
MY - Malesia 7
CL - Cile 6
ES - Italia 6
KE - Kenya 6
LT - Lituania 6
PE - Perù 6
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
PT - Portogallo 5
UZ - Uzbekistan 5
NI - Nicaragua 4
NP - Nepal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
SC - Seychelles 3
TN - Tunisia 3
CR - Costa Rica 2
EG - Egitto 2
GF - Guiana Francese 2
KG - Kirghizistan 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CM - Camerun 1
DJ - Gibuti 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
KI - Kiribati 1
LC - Santa Lucia 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.021
Città #
Singapore 719
Dublin 294
San Jose 287
Chandler 253
San Mateo 240
Hong Kong 229
Ashburn 208
Perugia 182
Boardman 165
Santa Clara 118
Moscow 97
Beijing 79
Lauterbourg 76
Altamura 75
Los Angeles 75
Seoul 74
Munich 64
Andover 60
Medford 59
Princeton 58
Lawrence 55
Wilmington 54
New York 52
Turku 51
Hanoi 45
Ho Chi Minh City 45
Ann Arbor 38
Vienna 36
The Dalles 30
Piscataway 29
São Paulo 27
Helsinki 26
Milan 26
Rome 26
Frankfurt am Main 25
Des Moines 22
London 20
Redmond 20
San Paolo di Civitate 20
Bologna 19
Jacksonville 19
Nuremberg 19
Brooklyn 17
Council Bluffs 17
Houston 17
Denver 16
Warsaw 16
Hefei 15
Norwalk 15
Orem 15
Dallas 14
Atlanta 13
Dearborn 13
Falls Church 13
Florence 13
Phoenix 13
Rio de Janeiro 13
Brno 12
Brussels 12
Johannesburg 12
Boston 11
Chicago 11
Saint Petersburg 11
Amsterdam 10
Quito 10
Stockholm 10
Tokyo 10
Toronto 10
Hải Dương 9
Lappeenranta 9
Montreal 9
Terni 9
Baghdad 8
Groningen 8
Guangzhou 8
Redwood City 8
West Jordan 8
Bucharest 7
Buffalo 7
Da Nang 7
Falkenstein 7
Izmir 7
Manchester 7
Marsciano 7
Poplar 7
Riyadh 7
Chennai 6
Foligno 6
Mexico City 6
Nairobi 6
Padova 6
San Francisco 6
Seattle 6
Secaucus 6
Ancona 5
Brasília 5
Kocaeli 5
Lima 5
Medellín 5
Mumbai 5
Totale 4.672
Nome #
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 144
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 139
"Designed" grafts for HLA-haploidentical stem cell transplantation. 126
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 125
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 124
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 121
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 121
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 119
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 118
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 118
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 115
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 114
T regulatory cell separation for clinical application. 113
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 111
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 109
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 108
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 106
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 103
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 102
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 100
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 99
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 98
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 97
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 97
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 94
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 94
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 93
T cells expressing chimeric antigen receptor promote immune tolerance 93
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 92
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 91
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 91
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 90
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 89
New mechanism of lymphoma-induced bone marrow aplasia 89
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 86
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 85
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 81
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 81
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 80
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 79
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 78
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 78
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 78
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 76
Chronic stimulation results in NK cell function impairment mediated by NKG2D 74
The Evolution of T Cell Depleted Haploidentical Transplantation 74
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 73
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 73
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 72
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 71
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 71
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 71
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 69
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 68
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 68
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 67
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 67
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 66
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 65
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 64
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 63
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 63
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 62
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 61
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 59
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 59
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 58
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 58
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 57
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 55
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 55
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 54
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 53
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 52
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 51
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 50
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 49
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 48
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 47
TIM-1 blockade of the donor graft provides protection against lethal GVHD 47
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 46
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 44
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 42
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 40
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 34
null 34
Role of donor regulatory T cell adoptive immunotherapy in B cell immunity after hematopoietic cell transplantation 32
null 27
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality 23
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 19
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone 16
CPX-351 Induces High Rate of Complete Remission in the New ICC/ELN 2022 Adverse-Risk Entity ‘AML with MDS-Related Gene Mutations’: Evidence from a Large Real-World Italian Study 15
Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia 6
Totale 7.251
Categoria #
all - tutte 36.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022645 0 199 1 15 29 7 10 175 11 25 101 72
2022/2023947 63 212 12 53 62 91 5 39 335 11 48 16
2023/2024584 15 59 14 14 2 14 118 8 41 26 127 146
2024/20251.339 41 126 49 59 176 86 72 101 237 77 196 119
2025/20263.007 220 215 157 404 403 251 520 167 286 265 76 43
2026/2027142 57 85 0 0 0 0 0 0 0 0 0 0
Totale 7.251